Market Trends of Europe Clinical Nutrition Industry
Metabolic Disorders Segment Expects to Witness a Significant Market Growth Over the Forecast Period
The metabolic disorders segment is expected to witness significant growth over the forecast period owing to factors such as the rising prevalence of metabolic disorders such as diabetes, Phenylketonuria (PKU), Porphyria, Gaucher Disease, and others among the population. For instance, according to the article published in June 2023 in the Cureus journal, PKU is one of the most well-known inborn metabolic disorders, with a prevalence of 1/100,000 live births in Europe. Thus, the high burden of metabolic diseases like PKU among the population is expected to increase the demand for nutrition therapy to control the levels of phenylalanine, which is expected to augment the market growth over the forecast period.
In addition, the rising geriatric population in the region is also contributing to the growth of the market. For instance, as per the October 2022 update by Eurostat, the population of older people in the EU-27 is expected to reach 129.8 million by 2050. The number of the elderly population is expected to increase shortly, who are more prone to metabolic, neurological, and other disorders. This is expected to raise the demand for clinical nutrition products, propelling the segment growth over the forecast period.
Furthermore, the increasing company activities for providing nutrition products to the people in the region are expected to increase the demand for clinical nutritional products, thereby boosting market growth. For instance, in March 2022, Cymbiotika launched a new e-commerce store in the United Kingdom that offers quick access to Cymbiotika's rapidly growing line of natural supplements. Additionally, in June 2022, Fresenius Kabi UK launched a website to support healthcare professionals working in the field of parenteral nutrition. This website contains information about the use of standardized parenteral nutrition and includes product information for the Fresenius Kabi range of multi-chamber bags.
Thus, the increasing burden of metabolic disorders, the growing geriatric population, and rising company activities in the region are expected to increase the demand for clinical nutrition therapy and products to reduce the risks of developing chronic diseases, which is expected to augment the market growth over the forecast period.
United Kingdom is Expected to Hold a Significant Market Share Over the Forecast Period
The United Kingdom is expected to witness significant growth in the studied market owing to factors such as an increase in malnutrition cases, a rise in awareness for clinical nutrition, and a surge in strategic initiatives by the key players. For instance, as per the January 2023 update by the Malnutrition Task Force in the UK, estimates suggest that 1.3 million people over 65 suffer from malnutrition, and the vast majority (93%) live in the community. Also, as per the same source, one-third (32%) of people in the UK aged 65 years or over are at risk of malnutrition on admission to the hospital. Thus, an increase in malnutrition cases is expected to increase the demand for clinical nutrition, thereby boosting the segment growth over the forecast period.
Furthermore, an increase in strategic activities by the key players and government initiatives to improve the clinical nutrition uptake are expected to bolster market growth. For instance, in March 2022, BSNA supported Nutrition and Hydration Week, which promoted good practices in preventing malnutrition and dehydration with health and social care professionals. Similarly, in October 2023, the British Association for Parenteral and Enteral Nutrition (BAPEN) joined forces with the Malnutrition Task Force (MTF) to run UK Malnutrition Awareness Week 2023 to increase the understanding of the dangers, risk factors, and signs of malnutrition and dehydration.
Therefore, due to the rise in malnutrition cases and the increase in awareness campaigns of clinical nutrition, the United Kingdom is expected to witness significant growth over the forecast period.
